According to a recent LinkedIn post from Vektor Medical Inc, the company is present at the HRS2026 conference in Chicago and engaging with the electrophysiology community. The post highlights demonstrations of its vMap technology at adjacent booths 1531 and 1532, emphasizing its use of non‑invasive ECG data to provide actionable insights for electrophysiologists.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post also points to a dedicated session in Rhythm Theater 2, where several electrophysiologists are scheduled to discuss their experience with vMap and emerging clinical evidence. For investors, this visibility at a major specialty conference may support clinician awareness, potential adoption, and future commercial traction, reinforcing Vektor Medical’s positioning in the medtech and cardiac electrophysiology markets.